Depression screening patterns, predictors, and trends among adults without a depression diagnosis in ambulatory settings in the United States
Psychiatric Services
Sandipan Bhattacharjee, Lisa Goldstone, Nina Vadiei, Jeannie K Lee, William J Burke
2018
This study examined national patterns, predictors, and trends in depression screening among adults without a diagnosis of depression in the United States.
Read More
Patterns and predictors of depression treatment among stroke survivors with depression in ambulatory settings in the United States
Journal of Stroke and Cerebrovascular Diseases
Sandipan Bhattacharjee, David Rhys Axon, Lisa Goldstone, Jeannie K Lee
2018
Despite the importance of treating depression, little is known regarding the current practice pattern of depression treatment among older adults with stroke and depression. We used national survey data from ambulatory settings to examine the depression treatment patterns and predictors among stroke survivors in the United States (US).
Read More
Patterns and Predictors of Depression Treatment among Older Adults with Parkinson’s Disease and Depression in Ambulatory Care Settings in the United States
Parkinson’s Disease
Sandipan Bhattacharjee, Nina Vadiei, Lisa Goldstone, Ziyad Alrabiah, Scott J Sherman
2018
Little is known regarding depression treatment patterns and predictors among older adults with comorbid Parkinson's disease and depression (dPD) in the United States (US). The objective of this study was to assess the patterns and predictors of depression treatment among older adults with dPD in the US. We adopted a cross-sectional study design by pooling multiple-year data (2005–2011) from the National Ambulatory Medical Care Survey (NAMCS) and the outpatient department of the National Hospital Ambulatory Medical Care Survey (NHAMCS). The final study sample consisted of visits by older adults with dPD. Depression treatment was defined as antidepressant use with or without psychotherapy. To identify predictors of depression treatment, multivariate logistic regression analysis was conducted adjusting for predisposing, enabling, and need factors. Individuals with dPD and polypharmacy were 74% more likely to receive depression treatment (odds ratio = 1.743, 95% CI 1.376–2.209), while dPD subjects with comorbid chronic conditions were 44% less likely (odds ratio = 0.559, 95% CI 0.396–0.790) to receive depression treatment. Approximately six out of ten older adults with PD and depression received depression treatment. Treatment options for dPD are underutilized in routine clinical practice, and further research should explore how overall medical complexity presents a barrier to depression treatment.
Read More
Curriculum in psychiatry and neurology for pharmacy programs
American Journal of Pharmaceutical Education
Julie A Dopheide, Jolene R Bostwick, Lisa W Goldstone, Kelan Thomas, Ruth Nemire, Kelly N Gable, Marshall Cates, Joshua Caballero, Tawny Smith, Jacquelyn Bainbridge
2017
To describe pharmacy curricula in psychiatry and neurology and to report on neuropsychiatric pharmacy specialists’ views on optimal curriculum.
Read More
Depression treatment among adults with multiple sclerosis and depression in ambulatory care settings in the United States
Multiple Sclerosis International
Sandipan Bhattacharjee, Lisa Goldstone, Queeny Ip, Terri Warholak
2017
There is little information regarding depression treatment patterns among adults with MS and depression in ambulatory settings at national level in the United States (US).
Read More
Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team.
Mental Health Clinician
Lisa W. Goldstone, Bethany A. DiPaula, Joshua Caballero, Susie H. Park, Cristofer Price, and Magdalena Zasadzki Slater
2015
Psychiatric pharmacists have specialized knowledge, skills, and training or substantial experience working with patients with psychiatric or neurologic disorders. As part of the collaborative team with a physician, psychiatric pharmacists can provide comprehensive medication management (CMM), a direct patient care service, to patients with psychiatric or neurologic disorders.
Read More